Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,848 | -7,559 | -5,697 | -4,005 | -2,304 |
| Accounts payable and accrued liabilities | -51 | -388 | -304 | -357 | 102 |
| Other Working Capital | -675 | -343 | -846 | -696 | 332 |
| Other Operating Activity | 94 | 532 | 418 | 433 | -65 |
| Operating Cash Flow | $-2,480 | $-7,758 | $-6,428 | $-4,625 | $-1,934 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,994 | 12,168 | 7,982 | 7,993 | 8,541 |
| Other Financing Activity | -91 | -50 | -51 | -50 | -50 |
| Financing Cash Flow | $1,903 | $12,118 | $7,931 | $7,944 | $8,492 |
| Beginning Cash Position | 7,522 | 3,162 | 3,162 | 3,162 | 3,162 |
| End Cash Position | 6,945 | 7,522 | 4,664 | 6,481 | 9,719 |
| Net Cash Flow | $-577 | $4,360 | $1,503 | $3,319 | $6,558 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,480 | -7,758 | -6,428 | -4,625 | -1,934 |
| Free Cash Flow | -2,480 | -7,758 | -6,428 | -4,625 | -1,934 |